The KHENERGY Study

NCT02909400 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Mitochondrial Diseases
Mitochondrial Myopathies
Mitochondrial Encephalomyopathies
MELAS
MIDD

Interventions

DRUG: KH176
DRUG: placebo

Sponsor

Khondrion BV

Collaborators

[object Object]